The U.S. organ donation system is facing increased scrutiny as the use of donation after circulatory death expands the pool of available organs [1].
This shift is critical because it increases the number of kidneys, livers, hearts, and lungs available for transplant patients. However, the rapid growth of this practice has led to reports of near-miss incidents and questions regarding whether ethical safeguards have kept pace with the clinical application [1], [2].
Donation after circulatory death, known as DCD, differs from traditional brain-death protocols. It allows for organ recovery after the heart stops beating and circulation ceases. This method has allowed surgeons to access a wider range of donors, potentially shortening the wait times for patients in critical need of transplants [1].
Despite the increase in available organs, the transition has not been without risk. Reports from July 2025 highlighted disturbing near-misses within the system [1]. These incidents have prompted calls for stricter patient protections to ensure that the drive to increase organ counts does not compromise the safety or dignity of the donors [1], [2].
Federal authorities have since aimed to improve donor and transplant safety [2]. The focus remains on balancing the urgent need for life-saving organs with the necessity of rigorous ethical oversight. Medical professionals are now evaluating how to standardize DCD practices to prevent the types of errors identified in recent reports [1].
As the system evolves, the medical community continues to weigh the benefit of expanded donor pools against the risks associated with the speed of implementation. The goal is to maintain a system that is both efficient in saving lives and uncompromising in its ethical standards [2].
“The rise of donation after circulatory death is expanding the organ pool but raising ethical concerns.”
The tension between increasing organ supply and maintaining ethical rigor represents a systemic challenge in U.S. healthcare. As DCD becomes more common, the medical community must formalize safeguards to ensure that the urgency of the transplant shortage does not lead to a degradation of donor protections or patient safety protocols.
